Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Medshine Discovery Inc.”

61 pharma patents match "Medshine Discovery Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 61
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 61 pharmaceutical patents matching "Medshine Discovery Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

61 results for “Medshine Discovery Inc.” · 30,257 patents in full index Clear search

  1. US 11433053

    LSD1 inhibitor and preparation method and application thereof

    Medshine Discovery Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted

  2. US 11384065

    Heterocyclic compound as CSF-1R inhibitor and use thereof

    Medshine Discovery Inc. · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted

  3. US 11377444

    Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors

    Medshine Discovery Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  4. US 11352331

    Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor

    Medshine Discovery Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  5. US 11345678

    Benzopyrazole compound used as RHO kinase inhibitor

    Medshine Discovery Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted

  6. US 11325907

    Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor

    Medshine Discovery Inc. · Granted May 10, 2022 · Expires May 5, 2042

    granted

  7. US 11319330

    Tricyclic furan-substituted piperidinedione compound

    Medshine Discovery Inc. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  8. US 11299482

    Salt and crystal form of modified andrographolide compound and preparation method thereof

    Medshine Discovery Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  9. US 11299475

    Prostacyclin receptor agonist

    Medshine Discovery Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  10. US 11254666

    Compound as GLS1 inhibitor

    Medshine Discovery Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  11. US 11230549

    Quinolino-pyrrolidin-2-one derivative and application thereof

    Medshine Discovery Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  12. US 11230544

    Substituted 1,3,4-thiadiazoles as GLS1 inhibitors

    Medshine Discovery Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  13. US 11198686

    Crystal form and salt form of pyridone compound and preparation method therefor

    Medshine Discovery Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  14. US 11192886

    S1P1 agonist and application thereof

    Medshine Discovery Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  15. US 11155523

    Biphenyl compound as CCR2/CCR5 receptor antagonist

    Medshine Discovery Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  16. US 11136315

    CXCR2 antagonist

    Medshine Discovery Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  17. US 11117899

    [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor

    Medshine Discovery Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

  18. US 11040984

    Quinazoline compound for EGFR inhibition

    Medshine Discovery Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  19. US 10995087

    Crystal form of URAT1 inhibitor, and preparation method therefor

    Medshine Discovery Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted

  20. US 10981860

    Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof

    Medshine Discovery Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  21. US 10851112

    Anti-HCMV virus compound

    Medshine Discovery Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  22. US 10717720

    Modified compound of andrographolide

    Medshine Discovery Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  23. US 10676474

    1,6-naphthyridine derivatives as CDK4/6 inhibitor

    Medshine Discovery Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  24. US 10647710

    Thiazole derivative and applications thereof

    Medshine Discovery Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.